Joshua R. Disbrow
2013 - Ampio Pharmaceuticals
In 2013, Joshua R. Disbrow earned a total compensation of $356.5K as Chief Operating Officer at Ampio Pharmaceuticals, a 66% decrease compared to previous year.
Compensation breakdown
Bonus | $127,500 |
---|---|
Salary | $228,958 |
Total | $356,458 |
Disbrow received $229K in salary, accounting for 64% of the total pay in 2013.
Disbrow also received $127.5K in bonus.
Rankings
In 2013, Joshua R. Disbrow's compensation ranked 10,380th out of 12,286 executives tracked by ExecPay. In other words, Disbrow earned more than 15.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,380 | 16th |
Manufacturing | 3,865 | 16th |
Chemicals And Allied Products | 1,227 | 16th |
Drugs | 966 | 16th |
Pharmaceutical Preparations | 753 | 15th |
Disbrow's colleagues
We found four more compensation records of executives who worked with Joshua R. Disbrow at Ampio Pharmaceuticals in 2013.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019